Ozone and P[M.sub.2.5] exposure and acute pulmonary health effects: a study of hikers in the Great Smoky Mountains National Park.

To address the lack of research on the pulmonary health effects of ozone and fine particulate matter ([less than or equal to] 2.5 [micro]m in aerodynamic diameter; P[M.sub.2.5]) on individuals who recreate in the Great Smoky Mountains National Park (USA) and to replicate a study performed at Mt. Washington, New Hampshire (USA), we conducted an observational study of adult (18-82 years of age) day hikers of the Charlies Bunion trail during 71 days of fall 2002 and summer 2003. Volunteer hikers performed pre- and posthike pulmonary function tests (spirometry), and we continuously monitored ambient [O.sub.3], P[M.sub.2.5], temperature, and relative humidity at the trailhead. Of the 817 hikers who participated, 354 (43%) met inclusion criteria (nonsmokers and no use of bronchodilators within 48 hr) and gave acceptable and reproducible spirometry. For these 354 hikers, we calculated the posthike percentage change in forced vital capacity (FVC), forced expiratory volume in 1 sec (FE[V.sub.1]), FVC/FE[V.sub.1], peak expiratory flow, and mean flow rate between 25 and 75% of the FVC and regressed each separately against pollutant ([O.sub.3] or P[M.sub.2.5]) concentration, adjusting for age, sex, hours hiked, smoking status (former vs. never), history of asthma or wheeze symptoms, hike load, reaching the summit, and mean daily temperature. [O.sub.3] and P[M.sub.2.5] concentrations measured during the study were below the current federal standards, and we found no significant associations of acute changes in pulmonary function with either pollutant. These findings are contrasted with those in the Mt. Washington study to examine the hypothesis that pulmonary health effects are associated with exposure to [O.sub.3] and P[M.sub.2.5] in healthy adults engaged in moderate exercise. Key words: air pollution epidemiology, fine particulate matter exposure, Great Smoky Mountains National Park, ozone exposure, pulmonary function, spirometry. Environ Health Perspect 114:1044-1052 (2006). doi:10.1289/ehp.8637 available via http://dx.doi.org/ [Online 9 February 2006]

**********

Both observational studies and controlled-chamber studies have been used to assess acute effects of air pollution on lung function in adults engaged in exercise or work (Aris et al. 1991; Avol et al. 1984; Brunekreef et al. 1994; Folinsbee et al. 1984, 1988; Gong et al. 1986; Hazucha 1987; Horstman et al. 1990; Kinney et al. 1996; Korrick et al. 1998; McBride et al. 1994; McDonnell et al. 1993, 1995, 1997; Naeher et al. 1999; Pekkanen et al. 2002; Selwyn et al. 1985; Spektor et al. 1988; Torres et al. 1997). Although fewer in number, observational studies offer the advantage of studying the effects of pollution on humans engaged in "real-world" activities in natural settings (Thurston and Ito 2001). However, they also have significant methodologic challenges. These include a) identifying an accessible population at risk whose exposures can be defined and adequately characterized, b) specifying measurable health outcomes, c) collecting an adequate amount of suitable quality-assured data on exposure and health outcomes, d) collecting sufficient data on other factors that may influence the exposure-outcome relationship, and e) the logistical issues of employing properly trained and motivated field technicians, finding cooperative subjects, and having a large enough sample size to adequately power the statistical analyses (Lippmann 1989).

In 1992 and 1993, Harvard University researchers performed a large observational study of day hikers at Mt. Washington in the White Mountain National forest of New Hampshire (Korrick et al. 1998). The Mt. Washington area is a popular site for outdoor recreation but is plagued with episodically high levels of ozone and fine particulate matter ([less than or equal to] 2.5 [micro]m in aerodynamic diameter; P[M.sub.2.5]) due to transported air pollutants and their precursors from surrounding industrial and urban areas (Korrick et al. 1998). Among the significant findings in the study were a 2.2% decline (p = 0.003) in forced vital capacity (FVC) and a 2.6% decline (p = 0.02) in forced expiratory volume in 1 sec (FE[V.sub.1]) for each 50 ppbv (parts per billion by volume) increment in mean [O.sub.3] and consistent associations of decrements in both FVC (0.4% decline, p = 0.001) and peak expiratory flow (PEF; 0.8% decline, p = 0.05) across the interquartile range for P[M.sub.2.5] concentration of 9 [micro]g/[m.sup.3] after adjusting for age, sex, smoking status, history of asthma or wheeze, hours hiked, ambient temperature, and other covariates.

The Great Smoky Mountains National Park is also a popular outdoor recreation area where ongoing monitoring has revealed high levels of air pollutants. Located in the southern Appalachian Mountains, the park encompasses 2,100 [km.sup.2] (520,000 acres) on the border of western North Carolina and eastern Tennessee. Approximately 95% of this acreage is forested, and elevations range from 267 to 2,021 m. With an average of > 8 million annual visitors since 1990, the park is one of the nation's most popular. Unfortunately, it also experiences levels of [O.sub.3] and P[M.sub.2.5] that exceed those in any other national park in the eastern United States and often exceed those in nearby cities (National Park Service Air Resources Division 2002). As of 2004, the entire park was classified by the U.S. Environmental Protection Agency (EPA) as a nonattainment area for the 8-hr National Ambient Air Quality Standard (NAAQS) of 80 ppbv, and a portion of the park was classified as nonattainment for the 24-hour P[M.sub.2.5] NAAQS of 65 [micro]g/[m.sup.3] (National Park Service Air Resources Division 2005). Furthermore, between 1990 and 2003, the Great Smoky Mountains was one of six national parks or federal lands to experience statistically significant increases in [O.sub.3] (U.S. EPA 2004b). As with the Mt. Washington area, the cause of these air quality problems is primarily the regional transport of air pollutants and their precursors from nearby metropolitan areas. For the Smoky Mountains, these areas include North Carolina, Georgia, Ohio, and Tennessee (National Park Service Air Resources Division 2002; Renfro 2002). Transported pollutants may then be sustained at elevated levels at higher elevation (> 1,000 m) sites, due primarily to geography and the lack of sources of nitric oxide to promote [O.sub.3] titration (Aneja and Li 1992; Malone 2003).

As a class I area protected under the federal Clean Air Act (1990), the park has air quality issues that have received much attention from the popular media (Barringer 2004), advocacy groups (National Parks Conservation Association 2004), the U.S. Congress (U.S. General Accounting Office 2001), and multi-organizational research efforts (Southern Appalachian Mountains Initiative 2002; Southern Oxidants Study 2002). Despite this attention, to our knowledge, no formal studies have been conducted in the park to document the possible health impacts of air pollution on people who recreate there.

To address this lack of research and to add to the epidemiologic literature on acute health effects of air pollution, we assessed the effects of [O.sub.3] and P[M.sub.2.5] on the pulmonary function of hikers at a popular recreation site in the park. Specifically, our primary goals were to determine whether the high levels of [O.sub.3] and P[M.sub.2.5] frequently observed in the Great Smoky Mountains National Park were associated with decrements in lung function of adult day hikers and to compare these findings with those reported in the Mt. Washington study.

Materials and Methods

We conducted an epidemiologic study of day hikers of the Charlies Bunion trail on 71 days over two periods: 10 August 2002 through 16 October 2002 (29 sampling days) and 17 June 2003 through 27 August 2003 (42 sampling days). The Charlies Bunion trail is an approximately 6.7 km portion (one-way) of the Appalachian Trail originating at Newfound Gap, a popular high-elevation (1.54 km) destination in the Great Smoky Mountains National Park.

Between 0900 and 1200 hr, we solicited adult ([greater than or equal to] 18 years of age) volunteers embarking on day hikes along the Charlies Bunion trail to participate in the study. In accordance with all federal guidelines governing use of human participants, we obtained written informed consent from those volunteers choosing to participate. This informed consent procedure was overseen by institutional review boards at both the University of Tennessee and Emory University. A participating hiker was then assigned a random four-digit code, and we obtained height and weight (with and without any hiking load) data. All researchers involved in data collection and analysis completed the National Institutes of Health Human Participant Protections Education for Research Teams online course (National Institutes of Health 2006) and any additional human subject protection education programs required by their respective universities' institutional review boards. Data collection days were rotated between two teams: one led by the University of Tennessee and one led by Emory University and Western Carolina University.

Pulmonary function testing (spirometry). To assess change in pulmonary function, we asked participants to perform spirometry both before their hike and when they returned from their hike. Spirometry technicians received 1-2 days of training by a licensed respiratory therapist in all aspects of performing spirometry. As part of this training, technicians were required to demonstrate proper techniques with mock volunteers and were trained by the respiratory therapist before being allowed to work on the study. Puritan-Bennett Renaissance II Spirometry Systems (Tyco Healthcare, Pleasanton, CA) were used to perform all spirometry.

Prehike pulmonary function tests were typically performed in the mornings (0900-1200 hr), and posthike tests were performed in the afternoons (1400-1900 hr) within 20 min of a hiker's return to the Newfound Gap trailhead. All tests were performed at 1.54 km above mean sea level inside a retrofitted research van that was equipped with two spirometry stations. Participants were tested in the seated position wearing nose clips and performed a minimum of three and a maximum of eight FVC maneuvers as recommended by the American Thoracic Society (ATS) standards (ATS 1995). Participants were required to have preand posthike testing performed by the same technician on the same machine.

On each sampling day, the spirometers were calibrated in the morning before prehike testing and in the afternoon before posthike testing using a fixed-volume, 3-L syringe. Tolerance limits for acceptable calibration were [+ or -] 3% (2.91-3.09 L) in accordance with American Association for Respiratory Care Clinical Practice Guidelines (American Association for Respiratory Care 1996).

To determine whether a hiker's pre- and posthike pulmonary function tests met the ATS acceptability criteria for inclusion in epidemiologic studies, each maneuver within both the pre- and posthike test sessions was evaluated by a pulmonary physician (R.A.O.). The physician, experienced with spirometry and blinded to the study hypothesis, inspected both the flow-volume and volume-time curves to ensure ATS standards were satisfied. Briefly, current (1994) ATS standards for acceptable spirometry include good start of test (an extrapolated volume of [less than or equal to] 5% of the FVC or 150 mL, whichever is greater), no hesitation or false start, a rapid start to rise time, no cough, especially during the first second of the maneuver, and no early termination of exhalation (unless there is no volume change for at least 1 sec or the subject cannot or should not continue to exhale further) (ATS 1995). For each hiker who gave at least two acceptable prehike and at least two acceptable posthike maneuvers, we assessed FVC and FE[V.sub.1] reproducibility criteria set forth by the ATS. These criteria require that the largest two FVC values from among acceptable maneuvers be within 0.2 L of each other and the largest two FE[V.sub.1] values from among acceptable maneuvers be within 0.2 L of each other (ATS 1995).

For each hiker who gave acceptable and reproducible pre- and posthike spirometry, we calculated the percentage change in five spirometric values: FVC, FE[V.sub.1], FE[V.sub.1]/FVC, PEF, and mean flow rate between 25% and 75% of the FVC (FE[F.sub.25-75%]). Percentage change was defined as 100 times the difference of the posthike value minus the prehike value divided by the prehike value. For FVC and FE[V.sub.1], we used the maximum prehike and posthike values from among those maneuvers that were acceptable and reproducible. Prehike and posthike values of FE[V.sub.1]/FVC, PEF, and FE[F.sub.25-75%] were taken from the single acceptable and reproducible maneuver with the maximum sum of FE[V.sub.1] and FVC (ATS 1995).

Trip log diary. Each participant was given a trip log diary to complete during the hike. Along the Charlies Bunion trail there are four National Park Service signs marking various points. These are the Newfound Gap trailhead, Sweat Heifer Creek Trail (2.7 km from Newfound Gap trailhead), Boulevard Trail turnoff (1.6 km from Sweat Heifer Creek Trail), Ice Water Spring Shelter (0.3 km from Boulevard Trail turnoff), and Charlies Bunion (2.1 km from Ice Water Spring Shelter). We provided digital watches, demonstrated proper technique for taking a pulse (radial or carotid), and instructed hikers to record their time of arrival and 15-sec pulse at designated location on ascent (trailhead to highest destination reached) and then on descent (highest destination reached to trailhead) and to note any special circumstances or deviations from the trail. Hikers were not asked to record respiratory symptoms along the hike.

Respiratory health symptoms and history questionnaire. After completing posthike spirometry, hikers responded to a modified version of the ATS Division of Lung Disease questionnaire (Ferris 1978). The standardized questionnaire obtained information on respiratory illness symptoms (cough, wheeze, phlegm, shortness of breath), history of respiratory illness (chest injury, heart trouble, bronchitis, pneumonia, pleurisy, pulmonary tuberculosis, hay fever, bronchial asthma), use of a bronchodilator within 48 hr, frequency and intensity of weekly aerobic activity, demographics (race, sex, age, marital status, education level, occupation), smoking status (never, current, former), and smoking history (if applicable).

[O.sub.3] and PM exposure assessment. Real-time ambient [O.sub.3] and P[M.sub.2.5] concentrations, along with temperature and relative humidity, were monitored on-site at the Newfound Gap trailhead on each study day. One-minute average [O.sub.3] concentrations were measured using a ultraviolet-absorption-based [O.sub.3] monitor (model 202; 2B Technologies, Boulder, Colorado). Dynamic calibration of the monitor was performed at the Knox County, Tennessee, Department of Air Quality Management's Air Quality Laboratory. We performed co-location studies at the Spring Hill Elementary monitoring site in Knoxville, Tennessee. Finally, because most of the Charlies Bunion trail is under forested canopy, we conducted a series of studies to assess a possible canopy effect--the potential reduction of [O.sub.3] concentration due to vegetative uptake and deposition. The details of these studies are presented elsewhere (Malone 2003). Briefly, the portable [O.sub.3] monitor was used to measure concentrations on the trail (under the canopy) and at the trailhead (outside of the canopy). From these studies, a canopy correction factor was developed for the exposure calculations to ensure that the measured [O.sub.3] concentrations accurately reflected a hiker's true [O.sub.3] exposure.

A [beta]-attenuation filter-based mass monitor (E-BAM; Met One Instruments, Grants Pass, OR) measured 1-hr average P[M.sub.2.5] concentrations. Co-location studies were performed with a continuous P[M.sub.2.5] monitor (tapered element oscillating microbalance) at the Look Rock monitoring station, and flow, temperature, and system calibrations were performed throughout the study.

The [O.sub.3] monitor was small enough to be attached to the E-BAM, and two 12-V DC batteries connected in parallel provided sufficient power for the monitors to run for at least 12 hr. All data were downloaded from the monitors directly onto a laptop computer.

On days where either portable monitor was not operating, we substituted values from two permanent monitoring stations maintained by the National Park Service: Clingmans Dome for [O.sub.3] (a high-elevation site 6.4 km from Newfound Gap, 2.0 km above mean sea level) and Look Rock for P[M.sub.2.5] (located on the eastern border of the park, 0.80 km above mean sea level). In both cases, we corrected the park's monitors to equivalent values for Newfound Gap based on correlations obtained from co-location studies. The correlation coefficients ranged from 0.6 to 0.9, indicating that correlations between the portable monitors and permanent monitors were adequate. Monitor failure occurred on approximately 15 sampling days for [O.sub.3] and 7 sampling days for P[M.sub.2.5].

Concentrations for [O.sub.3] and P[M.sub.2.5] were reported as 15-min average concentrations for use in exposure calculations. A time-weighted average pollutant ([O.sub.3] or P[M.sub.2.5]) concentration for each hiker was calculated by multiplying the average pollutant concentration in each discreet interval along the hike by the fraction of time spent in that interval. Times spent in each of the interval were taken from the trip log diary data. [O.sub.3] canopy corrections were made for portions of the hike under the forested canopy. In general, a 13% decrease in [O.sub.3] concentration was observed within the canopy (Malone 2003).

Fifteen-minute averages of temperature and relative humidity were measured at the trailhead on each study day, and an overall daily average was computed for use in all statistical models.

Statistical methods. To obtain an estimate of the relationship between [O.sub.3] and P[M.sub.2.5] exposure and change in pulmonary function, we used multiple linear regression, modeled by ordinary least squares estimation, as our primary method of analysis (PROC GLM; SAS Institute Inc., Cary, NC). The dependent variables in these analyses were the percentage change (posthike from prehike) in each of the five spirometric values: FVC, FE[V.sub.1], FE[V.sub.1]/FVC, PEF, and FE[F.sub.25-75%]. The two pollutant exposure variables, [O.sub.3] and P[M.sub.2.5], were considered the independent variables in the analysis.

To compare results between our study and the Mt. Washington study, we employed a similar modeling strategy. We fit separate regression models for each of the spirometric values as a function of each pollutant exposure. Both univariate and adjusted models were calculated. For the adjusted models, we selected a priori covariates based on those adjusted for in the Mt. Washington study. These included both continuous variables (age, hours hiked, and mean temperature) and categorical variables [sex, smoking status (former vs. never), history of asthma or wheeze symptoms, carrying a backpack, and reaching the summit]. In addition to these models, an adjusted piecewise linear regression model was fit for [O.sub.3] using an inflection point of 40 ppbv to determine whether or not different relationships were observed at higher concentrations.

Results

Study population. Over the 71 sampling days, 905 hikers initiated participation in the study. Of these hikers, 79 did not return for the posthike testing and an additional nine withdrew (either during pre- or posthike testing). A total of 817 (90.3%) returned for posthike spirometry testing.

Initial eligibility criteria included adult age ([greater than or equal to] 18 years), nonsmoker (had never smoked or had not smoked for 1 year before testing), no use of bronchodilator or asthma medication within 48 hr of testing, and day hikers who hiked at least to the Sweat Heifer trail marker. Among the 817 hikers who completed the study, 96 (12%) violated at least one of the initial inclusion criteria, and 721 (88%) were retained for further consideration. The most significant reasons for exclusion were smoking (n = 43 current smokers) and use of a bronchodilator within 48 hr of the test (n = 34).

Pulmonary function tests of these 721 hikers were then evaluated for inclusion in the analysis population as described previously. Of these hikers, 367 (50.9%) were excluded for failure to provide at least two acceptable and reproducible pre- and posthike pulmonary function tests. The most common reason for spirometric test failure was failure to blow out hard enough or long enough (~ 30%). This resulted in a final sample size for the analysis population of 354 hikers.

Selected demographic data for hikers included in the analysis population as well as those excluded are shown in Table 1. Most hikers were white (96%), never smoked (75%), and had no history of asthma or wheeze (82%). Sex was evenly divided, with a slight majority of females (56%). Age ranged from 18 to 82 years, with mean age of 43 years.

We tested for differences between those excluded due to spirometric test failure and those included in the analysis population using chi-square comparisons for categorical variables and two-sided t-tests for continuous variables. These results are shown in Table 1. Statistically significant differences (at the 5% level) were seen in sex (more males excluded) and, as a result, in baseline FE[V.sub.1] and FVC. Otherwise, the excluded hikers did not differ substantially from the analysis population.

Exposure assessment. [O.sub.3] and P[M.sub.2.5] concentrations were lower than anticipated at the onset of the study, and despite a record of frequent violations in past years, there were no exceedances of the current 8-hr NAAQS (80 ppbv) or the 24-hr standard for P[M.sub.2.5] (65 [micro]g/[m.sup.3]) during the study period (U.S. EPA 2004a). The average daily [O.sub.3] concentration measured at the Newfound Gap trailhead on the 71 study days was 52.0 [+ or -] 13.4 ppbv with a range of 27.6-79.3 ppbv. The average daily P[M.sub.2.5] concentration was 13.9 [+ or -] 8.2 [micro]g/[m.sup.3] with a range of 1.6-38.4 [micro]g/[m.sup.3].

Average daily temperature for the study days ranged from 2.6 to 24.1[degrees]C with a mean of 19.2 [+ or -] 4.4[degrees]C, and average daily relative humidity ranged from 48.2 to 93.9% with a mean of 73.6 [+ or -] 10.8%.

We computed [O.sub.3] and P[M.sub.2.5] concentrations for hikers included in the analysis data set (n = 354) using each hiker's time-weight average concentration including a correction for time spent under the canopy. (Table 1). [O.sub.3] concentrations ranged from 25.0 to 74.2 ppbv with a group mean of 48.1 [+ or -] 12.0 ppbv during exercise. P[M.sub.2.5] concentrations ranged from 0.21 to 41.9 [micro]g/[m.sup.3] with a group mean of 15.0 [+ or -] 7.4 [micro]g/[m.sup.3] during exercise. For comparison, concentrations were also computed for excluded hikers and are shown in Table 1.

Figures 1 and 2 show the hourly variation of P[M.sub.2.5] and [O.sub.3], respectively, on study days. In contrast to strong diurnal patterns in urban [O.sub.3], high-elevation sites typically display only small variation in [O.sub.3] concentrations throughout the day (Aneja et al. 2000). These data reflect this high-elevation [O.sub.3] pattern. P[M.sub.2.5] concentrations were also fairly constant throughout the day, with increases in the late afternoon (1500 hr and later). For both pollutants, 2003 levels were slightly higher than those observed in 2002. This was expected because of the seasonal difference between the 2002 and 2003 sampling periods (2002 sampling period was mostly during the fall and 2003 mostly during the summer).

For the 354 included hikers, the mean [O.sub.3] concentrations were significantly (p < 0.0001) correlated with mean P[M.sub.2.5] concentrations (Spearman r = 0.67). However, both pollutants were weakly but significantly associated with average daily temperature and relative humidity ([O.sub.3]: Spearman r = 0.16, p = 0.0039, and Spearman r = -0.59, p < 0.0001, respectively; P[M.sub.2.5]: Spearman r = 0.38, p < 0.0001, and Spearman r = -0.31, p < 0.0001, respectively).

Exercise profile. From the trip log diaries, we determined each hiker's highest destination reached, the total hiking distance (using the roundtrip distances from the National Park Service), and the total roundtrip hiking time (defined as time between prehike and posthike spirometry).

Selected exercise characteristics are also summarized in Table 1. Most included hikers (79%) carried a backpack or other load during their hike, with the average load weighing 4.1 [+ or -] 2.6 kg. Most (71%) also reached the peak (Charlies Bunion), with the average hiking distance of 12.2 [+ or -] 2.4 km and average hiking time of 5.0 [+ or -] 1.2 hr. There were no significant differences in the exercise profile compared with excluded hikers.

From the pulse data, we determined each hiker's maximum self-reported pulse (as number of beats per minute) and the percentage of age-predicted maximum pulse rates achieved, defined as 100 times the maximum self-reported pulse divided by 220 minus the hiker's age. For hikers included in the study, the mean percent maximum pulse achieved was 68 [+ or -] 13% with a range of 35-100%.

We also determined each hiker's baseline level of physical fitness by asking hikers about their typical exercise intensity and weekly frequency on the ATS-DLD questionnaire. Most (73%) indicated that they exercised at least 2 days per week, and most (72%) indicated that their exercise level was moderate or intense.

Pulmonary function response to exposure. The crude mean posthike percentage changes in each spirometric variable (FVC, FE[V.sub.1], FE[V.sub.1]/FVC, FE[F.sub.25-75%], PEF) were small and, in most cases, positive (Table 2). Only two spirometric variables--PEF and FE[V.sub.1]/FVC--had negative overall mean posthike percentage changes: 1.08% and -0.003%, respectively. Crude mean changes for FVC, FE[V.sub.1], and PEF were 0.24%, 0.15%, and 1.27%, respectively.

To explore a possible dose-response relationship between pollutant exposure and pulmonary function, we calculated the quintiles of the observed mean [O.sub.3] and P[M.sub.2.5] distributions and determined the mean posthike percentage change in selected spirometric variables--FVC, FE[V.sub.1], and PEF--within each quintile. These results are summarized in Tables 2 and 3 and displayed graphically in Figures 3 and 4 for P[M.sub.2.5] and [O.sub.3], respectively.

Across the quintiles of [O.sub.3] and P[M.sub.2.5] concentration, the prehike means of each of the pulmonary functions were similar. However, trends in mean posthike percentage changes across quintiles of either pollutant were not statistically significant for any spirometric variable. For FVC and FE[V.sub.1] with [O.sub.3], mean posthike percentage changes were positive with the exception of the first two quintiles (corresponding to [O.sub.3] concentrations of 35.3 and 43.5 ppbv); for FVC and FE[V.sub.1] with P[M.sub.2.5], only quintile 2 (corresponding to a P[M.sub.2.5] concentration of 11.1 [micro]g/[m.sup.3]). As Figures 3 and 4 show, the curves for FVC and FE[V.sub.1] are relatively constant, indicating little variation in response as a function of pollutant level.

The PEF response curves show a steady increase from -4.43% to 2.50% across quintiles of P[M.sub.2.5] concentration (Figure 3) and a steady increase from -1.51% to 1.99% across quintiles of [O.sub.3] concentration (Figure 4).

Multiple linear regression models. Results from multiple linear regression analyses of the percentage change between the pre- and posthike pulmonary function variables (FVC, FE[V.sub.1], FE[V.sub.1]/FVC, PEF, and FE[F.sub.25-75%]) and the time-weighted average concentration of [O.sub.3] and P[M.sub.2.5] during the hike period are presented in Table 3. Parameter estimates for the exposures, along with their respective p-values, are shown for both univariate and adjusted models. In the final adjusted models, we controlled for age, hours hiked, sex, smoking status (never or former), history of asthma or wheeze symptoms, carrying a backpack or other load, reaching the summit, and mean daily temperature. The adjusted models are based on a sample size of n = 339 because of missing temperature data for 15 hikers.

In most cases, regression slopes (in units of percent change/concentration) were small and not statistically significant. For example, the coefficient for the percent change in FE[V.sub.1] as a function of P[M.sub.2.5], adjusted for covariates, was 0.003%/[micro]g/[m.sup.3] with a p-value of 0.937, indicating that there was no association between P[M.sub.2.5] concentration and change in FE[V.sub.1] over the hike period. Similar interpretations of the coefficients of the other outcome variables and pollutant exposures may be made. Finally, F-tests for significant overall regression (data not shown) indicated that the adjusted models did not explain a significant amount of the variation in posthike pulmonary function change. The results from the piecewise model for [O.sub.3] with an inflection point of 40 ppbv did not produce different results. In all cases, except for PEF in the adjusted P[M.sub.2.5] models, the regression slopes were not statistically different from zero.

These conclusions were consistent across several subgroups. There was no change in statistical significance of the regression coefficients for those hikers with a self-reported history of asthma or wheeze (n = 62). To improve power, we defined two dichotomous categorical variables based on the ATS-DLD questionnaire responses: a respiratory symptom index based on a hikers' reporting of any positive symptom of respiratory illness (e.g., cough, cough with phlegm, shortness of breath; n = 176) and a respiratory health history index based on whether a hiker reported any positive history of respiratory or cardiovascular illness (e.g., heart trouble, bronchitis, pneumonia, asthma; n = 173) (Galizia and Kinney 1999). In both subgroups, mean lung function changes did not differ over the exposure levels, and both univariate and adjusted models resulted in no statistically significant associations. Finally, we restricted analyses to those > 50 years of age (n = 103), and our results were the same. We did not perform subanalyses on those with extreme lung function decrements (posthike percentage decrements of [greater than or equal to] 5% in FVC or FE[V.sub.1]) because of lack of sufficient sample (n = 40).

To evaluate whether meteorologic variables may have confounded the relationship between exposure and outcome, we computed regression models both with and without average daily temperature and relative humidity. In both cases, results did not change. We included temperature in our final models, however, to compare findings with the Mt. Washington study. We also computed multipollutant models, adjusting simultaneously for [O.sub.3] and P[M.sub.2.5]. As expected, because of the high correlations between the two pollutants, it was not possible to separate the effects in these models.

Comparison with the Mt. Washington study. Table 4 compares selected experimental variables between the Mt. Washington and Charlies Bunion (present) studies. The Mt. Washington study was performed on 74 days over 2 years. A total of 766 hikers initiated, with 530 (69%) meeting eligibility criteria. The Charlies Bunion study was performed on 71 days over 2 years. More hikers (n = 905) initiated the present study, but the inclusion rate was much smaller (39% compared with 69%). The primary reason for this difference in inclusion was spirometric test failure: fewer subjects in the Charlies Bunion study met ATS requirements for acceptability and reproducibility.

The demographics for both studies were similar. In both, most (96-97%) participants were white, never smokers (71-76%), and had no history of asthma or wheeze (82-92%). The average age was higher in the Charlies Bunion study: 46 compared with 35 in the Mt. Washington study. Finally, males composed a smaller percentage of included subjects (44% in the present study vs. 71% in the Mt. Washington study).

The exercise profile of included hikers in both studies was a significant point of difference. Although there were some similarities, including average maximum pulse rate (122 in the Mt. Washington study vs. 121 in the present study), percentage of age-predicted pulse (66% vs. 68% in the present study), and most reaching the summit and carrying a load, there was a significant difference in exercise (hiking) time. Mt. Washington hikers spent an average of 8 hr hiking, whereas Charlies Bunion hikers spent an average of 5 hr hiking. These differences are reflected in differing exposure levels. Despite similar air pollutant levels in both locations (Mt. Washington vs. Charlies Bunion, respectively: mean [O.sub.3], 40 vs. 47 ppbv; mean P[M.sub.2.5], 15 vs. 15 [micro]g/[m.sup.3]), the fact that the Mt. Washington study participants spent more time exercising translated into a higher exposure to pollutants.

Pulmonary function testing between the two studies was similar. In both cases, spirometry was performed in the seated position with nose clips. Posthike testing time was slightly later for the Mt. Washington study because of the longer hike time. One important difference, however, was the coaching. In the Mt. Washington study, only one spirometry technician certified by the National Institute for Occupational Safety and Health (NIOSH) conducted all tests. In the present study, however, 13 technicians were employed. These technicians were predominantly graduate students who had received 1-2 days of training from a certified respiratory therapist. Because spirometry is a highly effort-dependent test, the additional number of technicians may have introduced more variability in the measurements. Finally, baseline values of FE[V.sub.1] and FVC were slightly higher in the Mt. Washington study as a direct result of the larger percentage of males in their analysis population.

Table 5 directly compares selected findings for percentage change in pulmonary function as a function of ambient [O.sub.3] and P[M.sub.2.5] from the two studies. In the Mt. Washington study, adjusted linear models demonstrated statistically significant declines in FE[V.sub.1] (-0.051%/ppbv) and FVC (-0.043%/ppbv) with [O.sub.3] and statistically significant declines in FE[V.sub.1] (-0.041%/[micro]g/[m.sup.3]), FVC (-0.043%/[micro]g/[m.sup.3]), and PEF (-0.087%/[micro]g/[m.sup.3]) with P[M.sub.2.5]. In the Charlies Bunion study, linear models adjusting for the same variables did not demonstrate significant associations between posthike change in FE[V.sub.1] and FVC and either pollutant. However, in both studies, there were no significant associations with PEF, FE[V.sub.1]/FVC, or FE[F.sub.25-75%] and [O.sub.3].

Discussion

This study evaluated the hypothesis that exposure to ambient [O.sub.3] and P[M.sub.2.5] leads to acute respiratory effects, as measured by transient changes in pulmonary function, in healthy adults engaged in moderate exercise. Furthermore, we have added to the epidemiologic literature on acute health effects of air pollution by replicating another observational study of healthy adult hikers. To our knowledge, this was one of the first replications of a large-scale observational study of exercising adults. Although there were differences in findings between the two studies, consistent conclusions were reached.

We demonstrated that no statistically significant responses in pulmonary function occur when an average of 5.0 hr of outdoor exercise occurs at the levels of [O.sub.3] and P[M.sub.2.5] that we observed, some of which were substantially below the current NAAQS--80 ppbv for [O.sub.3] (8-hr) and 65 mg/[m.sup.3] for P[M.sub.2.5] (24-hr). Specifically, posthike percentage changes in FVC, FE[V.sub.1], FE[V.sub.1]/FVC, FE[F.sub.25-75%], and PEF were not associated with either [O.sub.3] or P[M.sub.2.5] exposure.

In studies where repeated pulmonary function tests are performed within the same day, it is important to assess confounding effects due to diurnal variation in lung function. It has been documented that expiratory flow and volume variables have minimum values early in the morning (0400-0600 hr) and peak around noon (Dockery and Brunekreef 1996). In our study, however, spirometric measurements were made at the same times (prehike, 0900-1200 hr; posthike, 1400-1900 hr) on all study days, regardless of pollution levels. This ensured that this confounding did not occur, but we assessed it quantitatively by computing regression models that were restricted to hikers whose prehike spirometric measurements were taken before 1100 hr and posthike measurement taken after 1500 hr (n = 135). Our results did not change.

A potential source of bias in our study was with the spirometry. It has been demonstrated that exclusion of subjects with unacceptable and nonreproducible measurements in studies of pulmonary function and health outcomes may lead to removing subjects with a more accelerated loss of lung function (Eisen et al. 1984). In this study, more than half of the participants were excluded because of spirometric test failure on either the pre- or posthike testing (or both). To assess this potential bias, we performed additional analyses of spirometric test failure using the full study population (n = 721). Full descriptions and results of these studies are presented elsewhere (Girardot 2005), but the relevant findings are briefly discussed here. Of the full study population, 700 (97%) hikers provided three complete maneuvers during both the prehike and posthike sessions and were included in these analyses. Spirometric test failure, as defined by the 1994 ATS standards and including both acceptability and reproducibility criteria for the top three maneuvers, was exhibited by 439 (62.7%) participants during prehike sessions and by 424 (60.6%) participants during posthike sessions. For both sessions, reproducibility criteria (both FVC and FE[V.sub.1]) for the top two maneuvers were achieved by > 80% of participants (prehike, 84.9%; posthike, 82.3%). Fewer than half of the hikers could perform three acceptable maneuvers during a test session (prehike, 40.3%; posthike, 45.0%), and slightly more could perform at least two acceptable maneuvers during a test session (prehike, 59.7%; posthike, 55.0%). We also sought to examine the association between spirometric test failure and a number of hiker characteristics, including age, sex, body mass index, respiratory health status, and respiratory health history using both stratified analyses and logistic regression modeling, where spirometric test failure was treated as the outcome (coded dichotomously as yes or no). We found no statistically significant associations at the 5% level. Finally, we examined models that included a technician variable as a predictor of test failure. There was no association between technician and spirometric test failure.

These findings imply that the most likely cause of test failure was poor coaching techniques. It has been well argued that achieving quality spirometry depends largely on the "skill and perseverance of the technician" (Enright et al. 2004). In our study, we were faced with the challenge of collecting data from unpaid volunteers in a nonclinical setting (on top of a mountain in a research van) who were generally unfamiliar with the technique and in a hurry to start their hike. Furthermore, we employed graduate students, senior undergraduates, and research assistants. Although they were all trained and approved by a certified respiratory therapist from the University of Tennessee, we realize that coaching volunteer participants--who were frequently uncooperative and/or hesitant--to achieve three acceptable and reproducible maneuvers was extremely difficult. As a result, our recommendations for any field study using spirometry is to employ only NIOSH-certified technicians and to minimize the number of technicians to help reduce the variability that could have been introduced by using different technicians on different days (NIOSH 2004).

Despite the loss of sample size because of poor spirometry, we must point out that the excluded population did not differ substantially from the included population (Table 1). For example, we did not have more hikers with asthma or wheeze excluded because of poor spirometry. In addition, our resulting sample size of n = 354 is higher than other studies examining similar hypotheses and is comparable with the Mt. Washington study population of n = 530. Finally, before being included in the analyses, each individual maneuver was carefully reviewed by an experienced pulmonary physician (R.A.O.) who was blinded to the study hypothesis. As a result, we feel that the conclusions reached would not differ had more participants been included in the analyses.

There were several additional limitations to our study. First, we could not assess minute ventilation of the hikers to determine a true pollution dose for each hiker. Maximum pulse was used as a proxy for exercise intensity (and hence dose), but this is not an adequate surrogate, because more fit subjects have lower minute ventilation and therefore receive a lower dose of pollutant. In addition, the study did not include children, and there was almost no participation from minority groups such as African Americans or Hispanics. Finally, by choosing to replicate the Mt. Washington study, we were constrained to follow similar protocols and procedures to allow the comparative analysis to be more meaningful. For example, one type of information not considered during this study or in the Mt. Washington study was an assessment of clinical symptoms of respiratory disease during the hike. The ATS, in defining what constitutes an adverse health effect, has stated that reduction in FE[V.sub.1] or FVC must be associated with clinical symptoms (e.g., cough or wheeze) (ATS 2000). Another variable both studies failed to measure was prehiking levels of pollutants. It could be argued that elevated levels of pollutants before the start of a hike might affect the health outcome, especially if these levels were higher than those experienced during the hike. However, we feel that because all of our subjects began their hikes in the morning, when pollution levels are typically at their lowest (even in urban areas), prehike pollution exposure was likely to be minimal. Further, in our study, most hikers arrived in automobiles, which offered some slight protection from air pollution. As a result, we do not feel that this was an issue in either study.

Air quality conditions during the study differed from what was initially predicted based on historical data. During the two study periods, the park had some of the best air quality in many years, due primarily to heavy rainfall. Rainfall "washes out" air pollutants, resulting in good air quality. As a result, the focus of the study shifted from modeling health effects at levels higher than the federal standards to modeling health effects at levels below the current federal standards. The findings from this study directly address the question of whether current federal standards are protective for human health in a healthy, exercising population.

Both this study and the Mt. Washington study examined the respiratory effects of relatively low concentrations of [O.sub.3] and P[M.sub.2.5]. One key difference between the two studies was the exposure duration. Mt. Washington hikers averaged 8.0 hr of exercise, whereas hikers in this study averaged 5.0 hr. However, these exercise periods were longer than in many previous field studies, which average exercise times of less than 2 hr. Another key difference was the mean age of the study populations. In the present study, the average age of the hikers was 46 years, compared with 35 in the Mt. Washington study. This is an important point of comparison, because older individuals may be less responsive to [O.sub.3] and PM than younger individuals. Although the Mt. Washington study found significant decrements in FVC and FE[V.sub.1] with both pollutants, the magnitude of the mean changes was small, and as the authors point out, "unlikely to result in clinical symptoms in most individuals" (Korrick et al. 1998). Furthermore, both studies failed to show significant associations in other spirometric variables--PEF, FE[V.sub.1]/FVC, or FE[F.sub.25-75%]--and [O.sub.3] and between FE[V.sub.1]/FVC or FE[F.sub.25-75%] and P[M.sub.2.5]. These findings are consistent with previous studies of lung function effects in nonasthmatic subjects. Relatively few observational studies have been conducted on healthy adults engaged in moderate exercise under typical outdoor conditions. For example, results of P[M.sub.2.5] peak flow analyses in several studies reported no consistent evidence for adverse health effects (Vedal 1998).

This study is one of the first designed and conducted, in part, to compare findings from two observational studies of acute respiratory illness and low levels of air pollution in adults engaged in outdoor exercise. Because large-scale observational studies, which are typically expensive and time-consuming to run, are relatively rare, the results obtained from this type of comparative study are important in the epidemiologic literature because they provide evidence (or lack of evidence) of associations between environmental exposure and health effects for individuals in natural settings. Our findings suggest that low levels of pollutant exposure over several hours may not result in significant declines in lung function in healthy adults engaged in exercise or work. However, there is considerable variation in individual response to pollutant exposure, and findings from epidemiologic studies--which rely on testing group means and other indicators--may not be entirely indicative of a lack of individual risk for adverse health effects due to air pollution. Finally, it may be difficult to separate the effects of the exercise or activity itself from the air pollution effects.

REFERENCES

American Association for Respiratory Care. 1996. AARC clinical practice guideline spirometry. Respir Care 41(7):629-636.

ATS (American Thoracic Society). 1995. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152(3):1107-1136.

ATS (American Thoracic Society). 2000. What constitutes an adverse health effect of air pollution? Official statement of the American Thoracic Society. Am J Respir Crit Care Med 161(2 pt 1):665-673.

Aneja VP, Adams AA, Arya SP. 2000. An observational based analysis of ozone trends and production for urban areas in North Carolina. Chemosphere Glob Change Sci 2:157-165.

Aneja VP, Li Z. 1992. Characterization of ozone at high elevation in the eastern United States: trends, seasonal variations, and exposure. J Geophys Res 97:9873-9888.

Aris R, Christian D, Sheppard D, Balmes JR. 1991. The effects of sequential exposure to acidic fog and ozone on pulmonary function in exercising subjects. Am Rev Respir Dis 143(1):85-91.

Avol EL, Linn WS, Venet TG, Shamoo DA, Hackney JD. 1984. Comparative respiratory effects of ozone and ambient oxidant pollution exposure during heavy exercise. J Air Pollut Control Assoc 34(8):804-809.

Barringer F. 2004. Critics say clean-air plan may be a setback for parks. New York Times (New York City, NY), 31 May: A12.

Brunekreef B, Hoek G, Breugelmans O, Leentvaar M. 1994. Respiratory effects of low-level photochemical air pollution in amateur cyclists. Am J Respir Crit Care Med 150(4):962-966.

Clean Air Act Amendments of 1990. 1990. Public Law 101-549. Available: www.epa.gov/oar/caa/caaa.txt [Accessed 25 May 2006].

Dockery DW, Brunekreef B. 1996. Longitudinal studies of air pollution effects on lung function. Am J Respir Crit Care Med 154(6 pt 2):S250-S256.

Eisen EA, Robins JM, Greaves IA, Wegman DH. 1984. Selection effects of repeatability criteria applied to lung spirometry. Am J Epidemiol 120(5):734-742.

Enright PL, Beck KC, Sherrill DL. 2004. Repeatability of spirometry in 18,000 adult patients. Am J Respir Crit Care Med 169(2):235-238.

Ferris BG. 1978. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 118(6 pt 2):1-120.

Folinsbee LJ, Bedi JF, Horvath SM. 1984. Pulmonary function changes after 1 h continuous heavy exercise in 0.21 ppm ozone. J Appl Physiol Respir Environ Exerc Physiol 57(4):984-988.

Folinsbee LJ, McDonnell WF, Horstman DH. 1988. Pulmonary function and symptom responses after 6.6-hour exposure to 0.12 ppm ozone with moderate exercise. J Air Pollut Control Assoc 38(1):28-35.

Galizia A, Kinney PL. 1999. Long-term residence in areas of high ozone: associations with respiratory health in a nationwide sample of nonsmoking young adults. Environ Health Perspect 107:675-679.

Girardot S. 2005. Association of Spirometric Test Failure and Respiratory Health Status in an Epidemiologic Field Study [MPH Thesis]. Atlanta, GA:Emory University Rollins School of Public Health.

Gong H Jr, Bradley PW, Simmons MS, Tashkin DP. 1986. Impaired exercise performance and pulmonary function in elite cyclists during low-level ozone exposure in a hot environment. Am Rev Respir Dis 134(4):726-733.

Hazucha MJ. 1987. Relationship between ozone exposure and pulmonary function changes. J Appl Physiol 62(4):1671-1680.

Horstman DH, Folinsbee LJ, Ives PJ, Abdul-Salaam S, McDonnell WF. 1990. Ozone concentration and pulmonary response relationships for 6.6-hour exposures with five hours of moderate exercise to 0.08, 0.10, and 0.12 ppm. Am Rev Respir Dis 142(5):1158-1163.

Kinney PL, Nilsen DM, Lippmann M, Brescia M, Gordon T, McGovern T, et al. 1996. Biomarkers of lung inflammation in recreational joggers exposed to ozone. Am J Respir Crit Care Med 154(5):1430-1435.

Korrick SA, Neas LM, Dockery DW, Gold DR, Allen GA, Hill LB, et al. 1998. Effects of ozone and other pollutants on the pulmonary function of adult hikers. Environ Health Perspect 106:93-99.

Lippmann M. 1989. Health effects of ozone: a critical review. J Air Pollut Control Assoc 39(5):672-695.

Malone RW. 2003. Ozone Monitoring and Canopy Effect in the Great Smoky Mountains National Park [MS Thesis]. Knoxville, TN:University of Tennessee.

McBride DE, Koenig JQ, Luchtel DL, Williams PV, Henderson WR Jr. 1994. Inflammatory effects of ozone in the upper airways of subjects with asthma. Am J Respir Crit Care Med 149(5):1192-1197.

McDonnell WF, Muller KE, Bromberg PA, Shy CM. 1993. Predictors of individual differences in acute response to ozone exposure. Am Rev Respir Dis 147(4):818-825.

McDonnell WF, Stewart PW, Andreoni S, Seal E Jr, Kehrl HR, Horstman DH, et al. 1997. Prediction of ozone-induced FE[V.sub.1] changes. Effects of concentration, duration, and ventilation. Am J Respir Crit Care Med 156(3 pt 1):715-722.

McDonnell WF, Stewart PW, Andreoni S, Smith MV. 1995. Proportion of moderately exercising individuals responding to low-level, multi-hour ozone exposure. Am J Respir Crit Care Med 152(2):589-596.

Naeher LP, Holford TR, Beckett WS, Belanger K, Triche EW, Bracken MB, et al. 1999. Healthy women's PEF variations with ambient summer concentrations of P[M.sub.10], P[M.sub.2.5], S[O.sub.4.sup.2-], [H.sup.+], and [O.sub.3]. Am J Respir Crit Care Med 160(1):117-125.

National Institutes of Health. 2006. Human Participant Protections Education for Research Teams. Washington, DC:U.S. Department of Health and Human Services. Available: http://cme.cancer.gov/clinicaltrials/learning/humanparticipant-protections.asp [accessed 25 May 2006].

National Park Service Air Resources Division. 2002. Air Quality in the National Parks. Washington, DC:U.S. Department of the Interior.

National Park Service Air Resources Division. 2005. FY 2004 Annual Performance Report: Government Performance and Results Act (GPRA) Air Quality Goals Ia3, Ia3B, and Ia3C. Washington, DC:U.S. Department of the Interior, National Park Service Air Resources Division.

National Parks Conservation Association. 2004. America's Ten Most Endangered National Parks. Available: http://www.npca.org/across_the_nation/ten_most_endangered/ [accessed 4 June 2004].

NIOSH. 2004. Spirometry Training Course. Cincinnati, OH:National Institute for Occupational Safety and Health. Available: http://www.cdc.gov/niosh/topics/spirometry [accessed 12 January 2005].

Pekkanen J, Peters A, Hoek G, Tiittanen P, Brunekreef B, de Hartog J, et al. 2002. Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease: the Exposure and Risk Assessment for Fine and Ultrafine Particles in Ambient Air (ULTRA) study. Circulation 106(8):933-938.

Renfro J. 2002. National Park Service Great Smoky Mountains National Park Briefing Statement. Gatlinburg, TN:Great Smoky Mountain National Park Service. Available: http://www.nps.gov/applications/parks/grsm/ppdocuments/AIR_BriefingStmt.PDF [acessed 26 May 2006].

Selwyn BJ, Stock TH, Hardy RJ, Chan FA, Jenkins DE, Kotchmar DJ, et al. 1985. Health effects of ambient ozone exposure in vigorously exercising adults. Trans Air Pollut Control Assoc TR-4:281-296.

Southern Appalachian Mountains Initiative. 2002. Final Report. Asheville, NC:Southern Appalachian Mountains Initiative. Available: http://www.enr.state.nc.us/newrefs/factsheet.pdf [accessed 26 May 2006].

Southern Oxidants Study. 2002. Policy Relevant Findings in Ozone and P[M.sub.2.5] Pollution Research 1994-2000. Raleigh, NC:North Carolina State University. Available: http://www.ncsu.edu/sos/pus/sos2/State_of_SOS_2.pdf [accessed 26 May 2006].

Spektor DM, Lippmann M, Thurston GD, Lioy PJ, Stecko J, O'Connor G, et al. 1988. Effects of ambient ozone on respiratory function in healthy adults exercising outdoors. Am Rev Respir Dis 138(4):821-828.

Thurston GD, Ito K. 2001. Epidemiological studies of acute ozone exposures and mortality. J Expo Anal Environ Epidemiol 11(4):286-294.

Torres A, Utell MJ, Morow PE, Voter KZ, Whitin JC, Cox C, et al. 1997. Airway inflammation in smokers and nonsmokers with varying responsiveness to ozone. Am J Respir Crit Care Med 156(3 pt 1):728-736.

U.S. EPA. 2004a. National Ambient Air Quality Standards. U.S. Environmental Protection Agency. Available: http://epa.gov/air/criteria.html [accessed 4 June 2004].

U.S. EPA. 2004b. The Ozone Report: Measuring Progress through 2003. Research Triangle Park, NC:U.S. Environmental Protection Agency.

U.S. General Accounting Office. 2001. Air Quality and Respiratory Problems in and near the Great Smoky Mountains. GAO-01-658. Washington, DC:U.S. General Accounting Office.

Vedal S, Petkau J, White R, Blair J. 1998. Acute effects of ambient inhalable particles in asthmatic and nonasthmatic children. Am J Respir Crit Care Med 157(4):1034-1043.

Steven P. Girardot, (1,2) P. Barry Ryan, (1,2) Susan M. Smith, (3) Wayne T. Davis, (4) Charles B. Hamilton, (3) Richard A. Obenour, (5) James R. Renfro, (6) Kimberly A. Tromatore, (3) and Gregory D. Reed (4)

(1) Department of Chemistry, and (2) Rollins School of Public Health, Emory University, Atlanta, Georgia, USA; (3) Department of Instructional Technology, Health, and Educational Studies, and (4) Department of Civil and Environmental Engineering, University of Tennessee, Knoxville, Tennessee, USA; (5) University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, USA; (6) National Park Service, Great Smoky Mountains National Park, Gatlinburg, Tennessee, USA

Address correspondence to P.B. Ryan, Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, 1518 Clifton Rd. NE, Atlanta, GA 30322 USA. Telephone: [phone]. Fax: [phone]. E-mail: [e-mail]

We gratefully acknowledge the National Park Service in the Great Smoky Mountains and the data collection teams from the University of Tennessee, Emory University, and Western Carolina University. We also thank C. Atterholt for overseeing the Western Carolina University health data collection team and C. Springer at the University of Tennessee for consultation on the statistical analyses. Finally, we are most grateful to the hikers for their enthusiastic participation in this study.

This research is supported by U.S. Environmental Protection Agency (EPA) grant X-97453102.

Although this research was funded by the U.S. EPA, it has not been subject to agency review and therefore does not necessarily reflect the views of the agency. No official endorsement is implied.

The authors declare they have no competing financial interests.

Received 7 September 2005; accepted 9 February 2006.

Table 1. Selected demographic, exercise, and exposure characteristics
for included and excluded hikers of the Charlies Bunion Trail in the
Great Smoky Mountains National Park, 2002-2003.

                              Included hikers
Characteristic                (n = 354)

Hike year
  2002                         85 (24)
  2003                        269 (76)
Demographics
  Race
    White                     339 (96)
    Nonwhite                   15 (4)
  Sex (male)                  154 (44)
  Age (years)                  43.2 [+ or -] 12.6 (18-82)
  Smoking status
    Former                     90 (25)
    Never                     264 (75)
  Baseline FE[V.sub.1] (L)      3.3 [+ or -] 0.77 (1.8-6.5)
  Baseline FVC (L)              4.3 [+ or -] 0.93 (2.0-7. 4)
  Asthma or wheeze history     62 (18)
Exposures
  Mean [O.sub.3]               48.1 [+ or -] 12.0 (25.0-74.2)
    (ppbv) (b,c)
  Mean P[M.sub.2.5]            15.0 [+ or -] 7.4 (0.21-41.9)
    ([micro]g/[m.sup.3]) (c)
  Mean temperature             20.3 [+ or -] 4.2 (2.6-24.1)
    ([degrees]C) (d)
  Mean relative humidity       71.3 [+ or -] 10.5 (48.2-93.9)
    (%) (e)
Exercise profile
  Reached summit              251 (71)
  Carried load                280 (79)
  Mean hike time (hr) (f)       5.0 [+ or -] 1.2 (1.8-9.0)
  Mean hike distance (km)      12.2 [+ or -] 2.4 (5.5-25.7)

                              Excluded hikers                  p-
Characteristic                (n = 367)                        Value (a)

Hike year
  2002                        150 (41)                          --
  2003                        217 (59)                          --
Demographics
  Race
    White                     351 (96)                           0.9355
    Nonwhite                   16 (4)
  Sex (male)                  222 (60)                         < 0.0001
  Age (years)                  43.3 [+ or -] 13.8 (18-82)        0.1108
  Smoking status
    Former                    103 (28)                           0.4232
    Never                     264 (72)
  Baseline FE[V.sub.1] (L)      3.5 [+ or -] 0.82 (1.1-8.5)      0.0079
  Baseline FVC (L)              4.6 [+ or -] 0.98 (1.9-9.5)      0.0001
  Asthma or wheeze history     52 (14)                           0.2184
Exposures
  Mean [O.sub.3]               45.8 [+ or -] 12.0 (23.7-74.0)    0.0106
    (ppbv) (b,c)
  Mean P[M.sub.2.5]            13.3 [+ or -] 7.7 (0-41.9)        0.0026
    ([micro]g/[m.sup.3]) (c)
  Mean temperature             19.6 [+ or -] 4.0 (2.6-24.1)      0.0250
    ([degrees]C) (d)
  Mean relative humidity       72.1 [+ or -] 11.0 (48.2-93.9)    0.3582
    (%) (e)
Exercise profile
  Reached summit              270 (74)                           0.4242
  Carried load                301 (82)                           0.321
  Mean hike time (hr) (f)       5.0 [+ or -] 1.2 (1.8-9.0)       0.4600
  Mean hike distance (km)      12.2 [+ or -] 2.2 (5.5-25.7)      0.8471

Values shown are mean [+ or -] SD (range) or number (%).
(a) p-Values shown compare included hikers with excluded hikers and were
computed by chi-square tests for categorical variables and two-sided
t-tests of means for continuous variables. (b) [O.sub.3] concentrations
have been corrected for canopy effects. (c) Values are based on hiker's
time-weight average concentration including a correction for time spent
under the canopy. (d) Values are based on the average daily temperature
on each hiker's test date. (e) Values are based on the average daily
relative humidity on each hiker's test date. (f) Defined as time between
prehike and posthike pulmonary function tests.

Table 2. Mean [+ or -] SE of spirometric values in each quintile of
P[M.sub.2.5] and [O.sub.3].

Quintile                    1 (n = 70) (a)       2 (n = 71)

P[M.sub.2.5]                 6.0                 10.4
  ([micro]g/[m.sup.3])
  Time (hr) (b)              5.0                  5.1
  FVC (L)
    Prehike                  4.32 [+ or -] 0.13   4.30 [+ or -] 0.11
    Posthike                 4.33 [+ or -] 0.12   4.30 [+ or -] 0.11
    %[DELTA] (c)            +0.12                +0.07
  FE[V.sub.1] (L)
    Prehike                  3.39 [+ or -] 0.10   3.42 [+ or -] 0.09
    Posthike                 3.40 [+ or -] 0.10   3.43 [+ or -] 0.09
    %[DELTA] (c)            +0.13                +0.44
  FE[V.sub.1]/FVC (%)
    Prehike                 78.66 [+ or -] 0.86  79.36 [+ or -] 0.71
    Posthike                78.63 [+ or -] 0.81  79.55 [+ or -] 0.69
    %[DELTA] (c)            +0.07                +0.30
  FE[F.sub.25-75%] (L/sec)
    Prehike                  3.27 [+ or -] 0.14   3.39 [+ or -] 0.14
    Posthike                 3.26 [+ or -] 0.14   3.38 [+ or -] 0.14
    %[DELTA] (c)            +1.40                +1.07
  PEF (L/sec)
    Prehike                  7.91 [+ or -] 0.22   8.37 [+ or -] 0.23
    Posthike                 7.58 [+ or -] 0.22   8.26 [+ or -] 0.25
    %[DELTA] (c)            -3.88                -1.14
[O.sub.3] (ppbv)            30.4                 42.1
  Time (hr) (b)              5.1                  4.9
  FVC (L)
    Prehike                  4.42 [+ or -] 0.13   4.28 [+ or -] 0.10
    Posthike                 4.38 [+ or -] 0.10   4.26 [+ or -] 0.10
    %[DELTA] (c)            -0.72                -0.40
  FE[V.sub.1] (L)
    Prehike                  3.48 [+ or -] 0.11   3.37 [+ or -] 0.08
    Posthike                 3.46 [+ or -] 0.11   3.35 [+ or -] 0.08
    %[DELTA] (c)            -0.61                -0.40
  FE[V.sub.1]/FVC (%)
    Prehike                 78.82 [+ or -] 0.86  78.70 [+ or -] 0.57
    Posthike                78.89 [+ or -] 0.82  78.86 [+ or -] 0.57
    %[DELTA] (c)            +0.19                +0.25
  FE[F.sub.25-75%] (L/sec)
    Prehike                  3.33 [+ or -] 0.15   3.20 [+ or -] 0.11
    Posthike                 3.35 [+ or -] 0.15   3.19 [+ or -] 0.11
    %[DELTA] (c)            +0.34                +1.02
  PEF (L/sec)
    Prehike                  8.32 [+ or -] 0.24   7.74 [+ or -] 0.21
    Posthike                 8.17 [+ or -] 0.14   7.45 [+ or -] 0.23
    %[DELTA] (c)            -1.34                -3.86

Quintile                    3 (n = 71)           4 (n = 71)

P[M.sub.2.5]                14.8                 17.9
  ([micro]g/[m.sup.3])
  Time (hr) (b)              5.0                  4.9
  FVC (L)
    Prehike                  4.34 [+ or -] 0.12   4.23 [+ or -] 0.11
    Posthike                 4.33 [+ or -] 0.12   4.23 [+ or -] 0.11
    %[DELTA] (c)            +0.16                +0.23
  FE[V.sub.1] (L)
    Prehike                  3.42 [+ or -] 0.10   3.36 [+ or -] 0.10
    Posthike                 3.40 [+ or -] 0.09   3.36 [+ or -] 0.10
    %[DELTA] (c)            -0.52                +0.18
  FE[V.sub.1]/FVC (%)
    Prehike                 79.20 [+ or -] 0.81  79.18 [+ or -] 0.81
    Posthike                78.83 [+ or -] 0.80  79.26 [+ or -] 0.79
    %[DELTA] (c)            -0.40                +0.17
  FE[F.sub.25-75%] (L/sec)
    Prehike                  3.19 [+ or -] 0.13   3.34 [+ or -] 0.15
    Posthike                 3.21 [+ or -] 0.13   3.30 [+ or -] 0.15
    %[DELTA] (c)            +1.05                +2.19
  PEF (L/sec)
    Prehike                  8.12 [+ or -] 0.25   7.75 [+ or -] 0.25
    Posthike                 7.89 [+ or -] 0.25   7.73 [+ or -] 0.26
    %[DELTA] (c)            -2.33                +0.76
[O.sub.3] (ppbv)            48.4                 54.7
  Time (hr) (b)              5.0                  5.1
  FVC (L)
    Prehike                  4.24 [+ or -] 0.12   4.23 [+ or -] 0.10
    Posthike                 4.29 [+ or -] 0.12   4.27 [+ or -] 0.11
    %[DELTA] (c)            -1.22                +0.86
  FE[V.sub.1] (L)
    Prehike                  3.34 [+ or -] 0.10   3.38 [+ or -] 0.08
    Posthike                 3.38 [+ or -] 0.10   3.39 [+ or -] 0.09
    %[DELTA] (c)            +1.48                +0.21
  FE[V.sub.1]/FVC (%)
    Prehike                 78.71 [+ or -] 0.96  80.01 [+ or -] 0.65
    Posthike                78.88 [+ or -] 0.93  79.51 [+ or -] 0.70
    %[DELTA] (c)            +0.30                -0.64
  FE[F.sub.25-75%] (L/sec)
    Prehike                  3.33 [+ or -] 0.15   3.33 [+ or -] 0.13
    Posthike                 3.26 [+ or -] 0.15   3.32 [+ or -] 0.13
    %[DELTA] (c)            +3.84                -0.06
  PEF (L/sec)
    Prehike                  8.19 [+ or -] 0.27   7.87 [+ or -] 0.23
    Posthike                 8.03 [+ or -] 0.28   7.90 [+ or -] 0.24
    %[DELTA] (c)            -1.56                +1.18

Quintile                    5 (n = 71)           Overall (n = 354)

P[M.sub.2.5]                25.6                 15.0
  ([micro]g/[m.sup.3])
  Time (hr) (b)              5.1                  5.0
  FVC (L)
    Prehike                  4.15 [+ or -] 0.11   4.27 [+ or -] 0.05
    Posthike                 4.18 [+ or -] 0.12   4.27 [+ or -] 0.05
    %[DELTA] (c)            +0.65                +0.24
  FE[V.sub.1] (L)
    Prehike                  3.31 [+ or -] 0.09   3.38 [+ or -] 0.04
    Posthike                 3.33 [+ or -] 0.10   3.38 [+ or -] 0.04
    %[DELTA] (c)            +0.51                +0.15
  FE[V.sub.1]/FVC (%)
    Prehike                 79.73 [+ or -] 0.66  79.2 [+ or -] 0.34
    Posthike                79.55 [+ or -] 0.64  79.2 [+ or -] 0.33
    %[DELTA] (c)            -0.16                 0.003
  FE[F.sub.25-75%] (L/sec)
    Prehike                  3.22 [+ or -] 0.14   3.28 [+ or -] 0.06
    Posthike                 3.24 [+ or -] 0.14   3.28 [+ or -] 0.06
    %[DELTA] (c)            +0.64                +1.27
  PEF (L/sec)
    Prehike                  7.72 [+ or -] 0.22   7.97 [+ or -] 0.11
    Posthike                 7.77 [+ or -] 0.23   7.97 [+ or -] 0.11
    %[DELTA] (c)            +1.12                -1.08
[O.sub.3] (ppbv)            64.6                 48.1
  Time (hr) (b)              5.1                  5.0
  FVC (L)
    Prehike                  4.17 [+ or -] 0.12   4.27 [+ or -] 0.05
    Posthike                 4.18 [+ or -] 0.11   4.27 [+ or -] 0.05
    %[DELTA] (c)            +0.24                +0.24
  FE[V.sub.1] (L)
    Prehike                  3.34 [+ or -] 0.10   3.38 [+ or -] 0.04
    Posthike                 3.33 [+ or -] 0.10   3.38 [+ or -] 0.04
    %[DELTA] (c)            +0.05                +0.15
  FE[V.sub.1]/FVC (%)
    Prehike                 79.86 [+ or -] 0.76  79.2 [+ or -] 0.34
    Posthike                79.69 [+ or -] 0.68  79.2 [+ or -] 0.33
    %[DELTA] (c)            -0.11                -0.003
  FE[F.sub.25-75%] (L/sec)
    Prehike                  3.23 [+ or -] 0.14   3.28 [+ or -] 0.06
    Posthike                 3.27 [+ or -] 0.15   3.28 [+ or -] 0.06
    %[DELTA] (c)            +1.19                +1.27
  PEF (L/sec)
    Prehike                  7.76 [+ or -] 0.24   7.97 [+ or -] 0.11
    Posthike                 7.69 [+ or -] 0.23   7.85 [+ or -] 0.11
    %[DELTA] (c)            +0.16                -1.08

(a) Sample size within each quintile of P[M.sub.2.5] or [O.sub.3]
concentration. (b) Time of exercise defined as difference between
prehike and posthike spirometry. (c) Percent change defined as 100 times
the difference of the posthike value minus the prehike value divided by
the prehike value.

Table 3. Univariate and adjusted multiple linear regression models of
the posthike percentage change in pulmonary function as a function of
ambient [O.sub.3] and P[M.sub.2.5].

                               FVC                    FE[V.sub.1]

P[M.sub.2.5] (univariate) (a)   0.023 [+ or -] 0.035   0.015 [+ or -]
                                  (p = 0.51)           0.029
                                                         (p = 0.607)
P[M.sub.2.5] (adjusted) (a,b)   0.007 [+ or -] 0.040   0.003 [+ or -]
                                  (p = 0.966)          0.033
                                                         (p = 0.937)
[O.sub.3] (univariate) (c)      0.015 [+ or -] 0.021   0.027 [+ or -]
                                  (p = 0.484)          0.018
                                                         (p = 0.145)
[O.sub.3] (adjusted) (b,c)      0.007 [+ or -] 0.024   0.024 [+ or -]
                                  (p = 0.763)          0.020
                                                         (p = 0.234)
[O.sub.3] (piecewise) (b,c,d)  -0.019 [+ or -] 0.037  -0.003 [+ or -]
                                 (p = 0.613)           0.032
                                                        (p = 0.911)

                               PEF                   FVC/FE[V.sub.1]

P[M.sub.2.5] (univariate) (a)  0.185 [+ or -] 0.091   0.003 [+ or -]
                                 (p = 0.043)          0.023
                                                        (p = 0.905)
P[M.sub.2.5] (adjusted) (a,b)  0.258 [+ or -] 0.103  -0.011 [+ or -]
                                 (p = 0.013)          0.027
                                                       (p = 0.676)
[O.sub.3] (univariate) (c)     0.089 [+ or -] 0.057  -0.017 [+ or -]
                                 (p = 0.118)          0.026
                                                       (p = 0.525)
[O.sub.3] (adjusted) (b,c)     0.118 [+ or -] 0.062  -0.028 [+ or -]
                                 (p = 0.059)          0.016
                                                       (p = 0.074)
[O.sub.3] (piecewise) (b,c,d)  0.127 [+ or -] 0.098  -0.025 [+ or -]
                                 (p = 0.195)          0.025
                                                       (p = 0.314)

                               FE[F.sub.25-75%]

P[M.sub.2.5] (univariate) (a)   0.052 [+ or -] 0.093
                                 (p = 0.578)
P[M.sub.2.5] (adjusted) (a,b)  -0.041 [+ or -] 0.109
                                 (p = 0.707)
[O.sub.3] (univariate) (c)     -0.051 [+ or -] 0.107
                                 (p = 0.634)
[O.sub.3] (adjusted) (b,c)     -0.041 [+ or -] 0.064
                                 (p = 0.523)
[O.sub.3] (piecewise) (b,c,d)  -0.045 [+ or -] 0.101
                                 (p = 0.659)

(a) Values shown are [beta]-coefficients for P[M.sub.2.5] exposure
in %/[micro]g/[m.sup.3] [+ or -] SEs. p-Values displayed are for the
coefficients. (b) Adjusted for age, hours hiked, sex, smoking status
(never or former), history of asthma, or wheeze symptoms, carrying a
backpack or load, reaching the summit, and mean daily temperature.
Because of missing temperature data, n = 339 participants were included
in these adjusted models. (c) Values shown are [beta]-coefficients for
[O.sub.3] in %/ppbv [+ or -] SEs. p-Values displayed are for the
coefficients. (d) Regression coefficients of piecewise model above
inflection point of 40 ppbv [O.sub.3].

Table 4. Comparison of selected variables for analysis populations in
the Mt. Washington and Charlies Bunion hiker studies.

Characteristic                 Mt. Washington       Charlies Bunion

No. initiating study            766                   905
No. included for analysis       530                   354
Inclusion rate (%)               69                    39
No. of study days                74                    71
Demographics
  Race [white (nonwhite)]       519 (97)              339 (96)
  Sex (male)                    375 (71)              154 (44)
  Age (years)                    35 [+ or -]           43 [+ or -]
                                 10 (18-64)             9 (19-82)
  Tobacco use (never vs.        405 (76)              264 (71)
    former)
  Asthma or wheeze               40 (8)                62 (18)
Exercise profile
  Elevation at trailhead (m     620                 1,538
    above sea level)
  Hiking time (hr)                8.0 [+ or -]          5.0 [+ or -]
                                  1.5 (2.0-12.0)        1.2 (1.8-9.0)
  Reached summit                396 (75)              251 (71)
  Carried load                  498 (94)              280 (79)
  Maximum pulse rate (beats/    122 [+ or -] 26       121 [+ or -] 23
    min)
  Percentage of age-predicted    66 [+ or -] 14        68 [+ or -] 13
    pulse (%) (a)
Pulmonary function testing
  Test condition of subjects   Seated with nose     Seated with nose
                                 clips                clips
  Prehike testing time         0800-1030 hr          0800-1200 hr
  Posthike testing time        1530-1930 hr          1530-1830 hr
  Baseline FE[V.sub.1] (L)        4.08 [+ or -]         3.38 [+ or -]
                                  0.81 (1.82-6.56)      0.80 (1.83-6.48)
  Baseline FVC (L)                5.13 [+ or -]         4.26 [+ or -]
                                  1.02 (2.89-7.93)      0.97 (1.96-7.45)
Exposures
  [O.sub.3] (ppbv)               40 [+ or -]           48 [+ or -]
                                 12 (21-74)            12 (25-74)
  P[M.sub.2.5] ([micro]g/        15 [+ or -]           15 [+ or -]
    [m.sup.3])                   13 (0.7-60)            7 (0.2-42)
  Trailhead temperature          17 [+ or -]           20 [+ or -]
    ([degrees]C)                  3 (8-25)              4 (3-24)

Values shown are number (%) or mean [+ or -] SD (range).
(a) Defined as maximum self-reported pulse divided by age-predicted
theoretical pulse (220-age) times 100%.

Table 5. Comparison of multiple linear regression models of the posthike
percentage change in pulmonary function as a function of ambient
[O.sub.3] and P[M.sub.2.5] in the Mt. Washington (n = 530) and Charlies
Bunion (n = 339) hiker studies.

                  [O.sub.3] regression models
                  Univariate               Adjusted (a)
                  MW           CB          MW           CB

FE[V.sub.1]       -0.045        0.015      -0.051       -0.001
                  (p = 0.01)   (p = 0.48)  (p = 0.02)   (p = 0.29)
FVC               -0.04         0.027      -0.043        0.011
                  (p = 0.001)  (p = 0.15)  (p = 0.003)  (p = 0.08)
PEF               -0.033        0.089      -0.018        0.224
                  (p = 0.48)   (p = 0.12)  (p = 0.76)   (p = 0.13)
FE[V.sub.1]/FVC   -0.005       -0.016      -0.009       -0.023
                  (p = 0.72)   (p = 0.27)  (p = 0.61)   (p = 0.56)
FE[F.sub.25-75%]  -0.005        0.006      -0.027       -0.026
                  (p = 0.93)   (p = 0.92)  (p = 0.70)   (p = 0.48)

                  P[M.sub.2.5] regression models
                  Univariate                 Adjusted (a)
                  MW            CB           MW            CB

FE[V.sub.1]       -0.035        0.023        -0.041        -0.002
                  (p = 0.02)    (p = 0.51)   (p = 0.03)    (p = 0.96)
FVC               -0.038        0.015        -0.043        -0.005
                  (p = 0.0004)  (p = 0.61)   (p = 0.0006)  (p = 0.88)
PEF               -0.084        0.185        -0.087         0.282
                  (p = 0.02)    (p = 0.043)  (p = 0.05)    (p = 0.01)
FE[V.sub.1]/FVC   NR            --           NR            --
FE[F.sub.25-75%]  NR            --           NR            --

Abbreviations: CB, Charlies Bunion (present) study; MW, Mt. Washington
study; NR, not reported.
(a) Adjusted for age, hours hiked, sex, smoking status (never or
former), history of asthma or wheeze symptoms, carrying a backpack or
load, reaching the summit, and mean daily temperature.